Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We use our state-of-the-art dedicated workflow for designing focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The procedure entails thorough molecular simulations of the catalytic and allosteric binding pockets, accompanied by ensemble virtual screening that factors in their conformational flexibility. When developing modulators, the structural modifications brought about by reaction intermediates are factored in to optimize activity and selectivity.
Several key aspects differentiate our library:
partner
Reaxense
upacc
Q68D91
UPID:
MBLC2_HUMAN
Alternative names:
Beta-lactamase MBLAC2; Metallo-beta-lactamase domain-containing protein 2; Palmitoyl-coenzyme A thioesterase MBLAC2
Alternative UPACC:
Q68D91; D6RJI1; Q8IY16; Q8N8D8
Background:
Acyl-coenzyme A thioesterase MBLAC2, also known as Beta-lactamase MBLAC2 and Metallo-beta-lactamase domain-containing protein 2, plays a crucial role in cellular metabolism. It catalyzes the hydrolysis of acyl-CoAs to free fatty acids and CoASH, regulating levels of acyl-CoAs, free fatty acids, and CoASH. MBLAC2 shows specificity for long-chain fatty acyl-CoA thioesters, particularly palmitoyl-CoA, and exhibits beta-lactamase activity, breaking down penicillin G and nitrocefin.
Therapeutic significance:
Understanding the role of Acyl-coenzyme A thioesterase MBLAC2 could open doors to potential therapeutic strategies.